🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ASCO guidelines: very helpful tool. Lung cancer living guidelines particularly useful given frequency of updates. #ASCO24

Dr. Matthew Gubens discussing all the available treatments in 2024 for oncogenic-driven #NSCLC ASCO #ASCO24 #lcsm

Thrilled to meet so many superstar ASCO volunteers at the President's Reception #asco24 #nerdcamp #minascheese gilberto lopes ElizBlanchardMD Matthew Gubens ANCO Manmeet Ahluwalia, MD, MBA, FASCO Tawasapon Thambamroong, M.D. Shaalan Beg MD MBA FASCO Bobby Daly

What a privilege to have served as Chair with the awesome ASCO Guidelines staff and volunteers. The committee is in great hands with Beverly Moy and @MDRoeland ! If you get the call to serve on a guideline, run, don’t walk! Evidence quality: High. Strength of recommendation:

We’ve issued a rapid guideline update for the management of stage III #NSCLC. ➡️ brnw.ch/21wKCWv #lungcancer #lcsm

We’ve issued a rapid guideline update on systemic therapy for #sclc. These recommendations are considered provisional pending full text review of publication and confirmation of data. ➡️ brnw.ch/21wKD3i #lungcancer #lcsm

Such warm hospitality from Indonesian oncologists! Representing #ASCOGuidelines @asco at their annual oncology meeting, ISMI HOTTI. Jakarta is the kota kolaborasi, or city of collaboration, indeed! Thanks Beverly Moy Christina Annunziata Nancy Baxter MD PhD for joining virtually! Thanks for having

Pleased to report the results of our clinical trial: Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung #JCO #EGFR ascopubs.org/doi/10.1200/JC… Thank you to all of the patients who participated.

Funny how CVS Health, Humana, & Aetna can unload unprofitable #MedicareAdvantage #patients only to have traditional #Medicare absorb them--what happens when #WallStreet runs #healthcare #healthinsurance healthcareuncovered.substack.com/p/americas-sen…

Medicare Disadvantage

Never underestimate a public school teacher.

With the rapid pace of data and new drug approvals in cancer, grateful for the contributions of the ASCO Evidence Based Medicine Committee members and volunteers from Australia to Alaska who review data and develop timely #ASCOGuidelines relevant to patient care now

So excited to co-organize Beyond Trauma Foundation Seattle Lung Cancer Conference with amazing chair Sid Devarakonda and co-chair Jessica Hellyer. Happening on 11/2 Saturday with fantastic speakers in Seattle! education.binayfoundation.org/content/2024-s…

⁦Matthew Gubens⁩ Excellent Presentation on KRAS Inhibitor Resistance #MaTOS24 ⁦Dr. Luis E. Raez⁩ ⁦Christine Lovly, MD, PhD, FASCO⁩ ⁦Marina Garassino⁩ ⁦Edgardo S. Santos, M.D., FACP, FASCO⁩ ⁦Triparna Sen (Sen-Lab)⁩

We assembled a great session at the 2024 MaTOS. Led by Dr. Christina Baik (chair), several important topics in NSCLC: KRAS (Dr. Gubbens), KEAP1/STK11 (Dr. Skoulidis), exon20ins (Dr. Piotrowska) and BRAF/NTRK (Dr. Villaruz). IASLC The Medical Educator Consortium The Oncology Institute Schmidt College of Medicine at Florida Atlantic

#MATOS24 Faculty Dinner/ Snow Fight ❄️☃️ Great ending to a great meeting!

Thank you Binay Shah, MD, MHA Jonathan Riess, MD MS Binaytara for inviting me to #SFLung25. Enjoyed meeting and learning from wonderful colleagues Matthew Gubens Surbhi Singhal Jyoti Malhotra Lei Deng, MD (He/Him) Ana I. Velázquez Mañana, MD, MSc, FASCO Collin Blakely MD, PhD Tina Li Dron Gauchan Natalia Colocci, Kim-Son Nguyen Sutter Health

Congratulations to new #ASCOGuidelines EBMC Chair Eric Roeland (cheers also to Chair-Elect Dr. Estela Rodriguez and Immediate Past Chair Beverly Moy, though you don’t need ankle injuries to serve!) We hit an inflection point this year, and I will be cheering you on from the sidelines!

Please check out our prospective, randomized trial just out in The Lancet Respiratory Medicine 🫁 Stage IA-IIA, non-squamous, surgically resected NSCLC 🧬 Molecular testing of resected tumor 💉 High-risk pts randomized 📉 Adjuvant chemo had DFS benefit vs observation authors.elsevier.com/sd/article/S22…